- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
GTx Inc+ Add to Watchlist
GTXI:US1.7900 USD 0.2300 14.74%
As of 17:20:00 ET on 12/20/2013.
Company Profile for GTx Inc (GTXI)
GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.
Key Executives for GTx Inc (GTXI)
|Mitchell S SteinerVice Chairman/CEO/Co-Founder||Marc S HanoverPresident/COO/Co-Founder|
|Mark E MostellerVP/CFO/Treasurer||Henry P DoggrellVP/Chief Legal Officer/Secy|
|James T DaltonVP/Chief Scientific Officer||Domingo RodriguezVP:Clinical Operations|
|Mary Ann JohnstonVP:Medical Affairs||Jeffrey G HesselbergVP:Regulatory Affairs|